Gonorrhea
Major vaccine developments put new shots on market in 2023
Major vaccine developments in 2023 included the approvals of the first two vaccines against respiratory syncytial virus, the first chikungunya vaccine, a new vaccine against malaria, and a move to new monovalent COVID-19 vaccines.
Hospital intervention increased STI testing among at-risk adolescents
A hospital in California increased testing for chlamydia and gonorrhea among high-risk adolescents by nearly fivefold in its pediatric ED by implementing several interventions, including preselected order panels for physicians and nurses.
Prevention is key: A guide to STI prophylaxis
In the United States, there were approximately 1.6 million cases of chlamydia, 710,000 cases of gonorrhea and 176,000 cases of syphilis reported in 2021, according to the CDC.
More than two-thirds of people diagnosed with mpox had prior STIs
Prior infections with chlamydia and/or gonorrhea were common among people diagnosed with mpox, according to data gathered and assessed by the Chicago Department of Public Health.
VIDEO: Gonorrhea vaccine trial nears full enrollment
BOSTON — In this video, Jodie A. Dionne, MD, MSPH, associate professor of medicine at the University of Alabama at Birmingham, recaps her IDWeek presentation on vaccines and sexually transmitted infections.
VIDEO: What to know about CDC’s draft guidance on doxy-PEP
BOSTON — In this video from IDWeek, Annie Luetkemeyer, MD, discusses the CDC’s pending recommendations for prescribing doxycycline as post-exposure prophylaxis for sexually transmitted infections.
Intensively screening people at low risk for N. gonorrhoeae has little impact on transmission
A network-based model demonstrated that men who have sex with men drive the Neisseria gonorrhoeae epidemic and that intensive screening in the low-risk population had little impact on decreasing transmission rates.
Top in ID: STD epidemic worsens; SARS-CoV-2 surged in hospitals
The number of reported cases of chlamydia, gonorrhea and syphilis in the United States increased between 2020 and 2021, CDC data show.
Vaginal swabs preferred over urine samples for chlamydia, gonorrhea testing
Evidence from nearly 30 studies support vaginal swabs as the optimal specimen for chlamydia and gonorrhea testing rather than urine samples, with the latter representing a “disservice” with long-term consequences, according to researchers.
FDA grants clearance for fast, point-of-care STI test for women
The FDA has granted 501(k) clearance and a Clinical Laboratory Improvement Amendments waiver for a polymerase chain reaction diagnostic test to detect sexually transmitted infections in women, according to a press release.